Moleculin Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
CEOWalter V. Klemp
CEOWalter V. Klemp
Employees18
Employees18
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2015
Founded2015
Employees18
Employees18
MBRX Key Statistics
Market cap11.45M
Market cap11.45M
Price-Earnings ratio-0.33
Price-Earnings ratio-0.33
Dividend yield—
Dividend yield—
Average volume20.79K
Average volume20.79K
High today$5.50
High today$5.50
Low today$4.80
Low today$4.80
Open price$5.04
Open price$5.04
Volume101.19K
Volume101.19K
52 Week high$15.75
52 Week high$15.75
52 Week low$4.28
52 Week low$4.28
MBRX News
TipRanks 3h
Moleculin Biotech Shares Corporate Update Online - TipRanks.com - TipRanksMoleculin Biotech (MBRX) has issued an update. Moleculin Biotech, Inc. is presenting its corporate presentation on its website on May 7, 2024, offering a glimp...
TipRanks 10h
Moleculin Biotech Shares Upbeat Annamycin AML Trial Update - TipRanks.com - TipRanksMoleculin Biotech (MBRX) has provided an update. Moleculin Biotech, Inc. has released promising interim data for Annamycin in its ongoing AML (Acute Myeloid Le...